• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL INC. REDIGUARD IAB: 8FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL INC. REDIGUARD IAB: 8FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC Back to Search Results
Model Number IPN000263
Device Problem Difficult to Advance (2920)
Patient Problem Death (1802)
Event Date 07/02/2020
Event Type  malfunction  
Manufacturer Narrative
(b)(4).
 
Event Description
It was reported that during intra-aortic balloon pump (iabp) counterpulsation procedure it was noted that the intra-aortic balloon ( iab) could not pass through the sheath, so it was withdrawn.Subsequently, it was found that the patient's heart was arrested, and the cardiopulmonary resuscitation was unable to recover his heartbeat, and the patient died.The doctor zehan huang made the medical judgement that the device did not cause or contribute to the patient's death.
 
Event Description
It was reported that during intra-aortic balloon pump (iabp) counterpulsation procedure it was noted that the intra-aortic balloon ( iab) could not pass through the sheath, so it was withdrawn.Subsequently, it was found that the patient's heart was arrested, and the cardiopulmonary resuscitation was unable to recover his heartbeat, and the patient died.The doctor zehan huang made the medical judgement that the device did not cause or contribute to the patient's death.
 
Manufacturer Narrative
(b)(4).Teleflex received the device for investigation.The reported complaint that the "balloon could not pass through the sheath" is not able to be confirmed.The sheath in question was not returned for investigation.The returned intra-aortic balloon catheter (iabc) bladder membrane passed dimensional and functional inspection.The root cause of the complaint is undetermined.A device history record (dhr) review was conducted for the lot number with no relevant findings.The device passed all manufacturing specifications prior to release.Teleflex assessed the risk for the reported complaint.There are no new or revived risk.This will be monitored for any developing trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REDIGUARD IAB: 8FR 40CC
Type of Device
SYSTEM, BALLOON, INTRA-AORTIC
Manufacturer (Section D)
ARROW INTERNATIONAL INC.
reading PA
MDR Report Key10634913
MDR Text Key210017897
Report Number3010532612-2020-00285
Device Sequence Number1
Product Code DSP
UDI-Device Identifier00801902002679
UDI-Public00801902002679
Combination Product (y/n)N
PMA/PMN Number
K981660
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 09/17/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/06/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2021
Device Model NumberIPN000263
Device Catalogue NumberIAB-S840C
Device Lot Number18F19K0052
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/28/2020
Date Manufacturer Received11/05/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-